Inovio (INO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend ...

PLYMOUTH MEETING, Pa. - INOVIO (NASDAQ: INO), a biotechnology company with a market capitalization of approximately $69 million, has announced positive results from a Phase 1/2 clinical trial of ...

Inovio (INO) announced that peer-reviewed data from its Phase 1/2 clinical trial with INO-3107 as a potential treatment for recurrent ...

This was the stock's fourth consecutive day of losses.

This was the stock's third consecutive day of losses.

Synnovation Therapeutics, founded in 2021, worked with the Delaware Prosperity Partnership to secure a $438,000 state jobs performance grant from the state's Strategic Fund to support the workforce ...

Cardinal Health (NYSE:CAH) reported its second-quarter earnings for fiscal year 2024, surpassing analyst expectations with an ...

Microsoft's recent report has investors wondering if the company's stock is overvalued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting ...

Detailed price information for Inovalis REIT (INO-UN-T) from The Globe and Mail including charting and trades.

PLYMOUTH MEETING, Pa., Jan. 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV ...

During the conference, Dr. Shea and members of INOVIO's management team will conduct one-on-one meetings with registered investors. A webcast of the presentation will be available on the INOVIO ...

TORONTO, January 09, 2025--Inovalis Real Estate Investment Trust (the "REIT") (TSX: INO.UN) today announced the signing of an exchange contract for the sale of 87.5% of the Arcueil property to two ...